Mary Norton, MD

Chair, Obstetrics, Gynecology and the Reproductive Sciences
Perinatologist and Medical Geneticist

Mary E. Norton is a perinatologist and clinical geneticist at UCSF Medical Center's Prenatal Diagnostic Center. She primarily cares for pregnant women who have a fetus with a birth defect or genetic disorder or are at risk for such a condition. Norton performs obstetrical ultrasounds, counsels women in whom ultrasound detects a problem with the fetus and performs such prenatal tests as amniocentesis and chorionic villus sampling. She also interprets complex genetic tests, especially when abnormalities are found. Her areas of interest in research include applying new genetic tests to prenatal diagnosis and fetal disease, as well as patient decision-making around genetic testing and obstetrical ultrasound. She is also the chair of the obstetrics, gynecology and reproductive sciences at UCSF.

Norton earned her undergraduate degree at the University of Washington in 1982. She completed her internship and residency in Obstetrics and Gynecology at Tuft University in Boston in 1990. She completed a fellowship in Maternal Fetal Medicine and Clinical Genetics at UCSF in 1993. After several years at Brigham and Women's Hospital and Harvard Medical School, she returned to San Francisco where she joined UCSF Medical Center in 1998. She is a professor of obstetrics, gynecology and reproductive sciences at UCSF.

Clinics

Fetal Treatment Center
1855 Fourth St., Second Floor, Room A-2432
San Francisco, CA 94158
Phone: (800) 793-3887
Fax: (415) 502-0660

Hours: Monday to Friday
8 a.m. - 5 p.m.

Prenatal Diagnostic Center
1825 Fourth St., Third Floor
San Francisco, CA 94158
Phone: (415) 476-4080
Fax: (415) 353-4077

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Clinical Genetics, American Board of Medical Genetics

Academic Title

Professor
Interim Chair

More about Mary Norton

Education

University of Washington School of Medicine 1986

Residencies

Tufts-New England Medical Center, OB/GYN 1987

Fellowships

Tufts-New England Medical Center, OB/GYN 1990
UCSF Medical Center, Genetics/Maternal Fetal Medicine 1993

Selected Research and Publications

  1. Steurer MA, Baer RJ, Keller RL, Oltman S, Chambers CD, Norton ME, Peyvandi S, Rand L, Rajagopal S, Ryckman KK, Moon-Grady AJ, Jelliffe-Pawlowski LL. Gestational Age and Outcomes in Critical Congenital Heart Disease. Pediatrics. 2017 Sep 08.
  2. Norton ME. Expanded Carrier Screening: A Rational Approach to Screening for Rare Diseases. Obstet Gynecol. 2017 Aug; 130(2):260-261.
  3. Moon-Grady AJ, Baschat A, Cass D, Choolani M, Copel JA, Crombleholme TM, Deprest J, Emery SP, Evans MI, Luks FI, Norton ME, Ryan G, Tsao K, Welch R, Harrison M. Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet). Fetal Diagn Ther. 2017 May 23.
  4. Steurer MA, Peyvandi S, Baer RJ, MacKenzie T, Li BC, Norton ME, Jelliffe-Pawlowski LL, Moon-Grady AJ. Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset. J Pediatr. 2017 Aug; 187:182-188.e3.
  5. Bude J, Carr CW, Miller PE, Parham T, Whitman P, Monticelli M, Raman R, Cross D, Welday B, Ravizza F, Suratwala T, Davis J, Fischer M, Hawley R, Lee H, Matthews M, Norton M, Nostrand M, VanBlarcom D, Sommer S. Particle damage sources for fused silica optics and their mitigation on high energy laser systems. Opt Express. 2017 May 15; 25(10):11414-11435.
  6. Norton ME. Prenatal screening: it is not just about Down syndrome. BJOG. 2017 Jul; 124(8):1162.
  7. Sparks TN, Thao K, Norton ME. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes? Genet Med. 2017 Apr 06.
  8. Steurer MA, Norton ME, Baer RJ, Shaw GM, Keating S, Moon-Grady AJ, Chambers CD, Jelliffe-Pawlowski LL. The association of maternal lymphatic markers and critical congenital heart defects in the fetus-A population based case-control study. Am J Med Genet A. 2017 May; 173(5):1231-1236.
  9. Chetty S, Norton ME. Obstetric care in women with genetic disorders. Best Pract Res Clin Obstet Gynaecol. 2017 Jul; 42:86-99.
  10. Norton ME, Biggio JR, Kuller JA, Blackwell SC. The role of ultrasound in women who undergo cell-free DNA screening. Am J Obstet Gynecol. 2017 Mar; 216(3):B2-B7.
  11. Baer RJ, Chambers CD, Ryckman KK, Oltman SP, Norton ME, Jelliffe-Pawlowski LL. Risk of preterm birth among women using drugs during pregnancy with elevated a-fetoprotein. J Perinatol. 2017 Mar; 37(3):220-225.
  12. Norton ME. Noninvasive prenatal testing to analyze the fetal genome. Proc Natl Acad Sci U S A. 2016 Dec 13; 113(50):14173-14175.
  13. Norton ME, Kuppermann M. Women should decide which conditions matter. Am J Obstet Gynecol. 2016 Nov; 215(5):583-587.e1.
  14. Sparks TN, Norton ME, Flessel M, Goldman S, Currier RJ. Observed Rate of Down Syndrome in Twin Pregnancies. Obstet Gynecol. 2016 Nov; 128(5):1127-1133.
  15. Norton ME. What Is New in the Prevention of Preeclampsia?: Best Articles From the Past Year. Obstet Gynecol. 2016 Sep; 128(3):651-2.
  16. Sheibani L, Fong A, Henry DE, Norton ME, Truong YN, Anyikam A, Laurent LC, Rao R, Wing DA. Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32 to 33 6/7 weeks gestational age. J Matern Fetal Neonatal Med. 2017 Jul; 30(14):1676-1680.
  17. Premkumar A, Henry DE, Moghadassi M, Nakagawa S, Norton ME. The interaction between maternal race/ethnicity and chronic hypertension on preterm birth. Am J Obstet Gynecol. 2016 Dec; 215(6):787.e1-787.e8.
  18. Isquick S, Henry D, Nakagawa S, Moghadassi M, Thiet MP, Norton M, Lucero J. The association between nitroglycerin use and adverse outcomes in women undergoing cesarean delivery in the second stage of labor. J Matern Fetal Neonatal Med. 2017 Jun; 30(11):1297-1301.
  19. Yang J, Baer RJ, Berghella V, Chambers C, Chung P, Coker T, Currier RJ, Druzin ML, Kuppermann M, Muglia LJ, Norton ME, Rand L, Ryckman K, Shaw GM, Stevenson D, Jelliffe-Pawlowski LL. Recurrence of Preterm Birth and Early Term Birth. Obstet Gynecol. 2016 Aug; 128(2):364-72.
  20. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016 Oct; 215(4):B2-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.